GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate

25 Jan 2024 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder, details of which are enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2621.00 -29.85 (-1.13%)
26-Feb-2026 11:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.60
Dr. Reddys Lab 1313.80
Cipla 1350.10
Zydus Lifesciences 936.60
Lupin 2320.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×